Back
RAPT Therapeutics 10K Form
Sell
21
RAPT
RAPT Therapeutics
Last Price:
8.97
Seasonality Move:
35.34%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RAPT News And Ratings
See the #1 stock for the next 7 days that we like better than RAPT
RAPT Financial Statistics
Sales & Book Value
Annual Sales: | $1.53M |
---|---|
Cash Flow: | $-27.82M |
Price / Cash Flow: | 0 |
Annual Sales: | $4.27 |
Price / Book: | 2.11 |
Profitability
EPS (TTM): | -3.05000 |
---|---|
Net Income (TTM): | $-116.8M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
RAPT Therapeutics Earnings Forecast
Key RAPT Therapeutics Financial Ratios
- Per Share Earnings over the last 7 years have been positive in 1 years.
RAPT Therapeutics Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Healthcare |
Current Symbol: | RAPT |
CUSIP: | 75382E |
Website: | rapt.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
RAPT Technical Analysis vs Fundamental Analysis
Sell
21
RAPT Therapeutics (RAPT)
is a Sell
Is RAPT Therapeutics a Buy or a Sell?
-
RAPT Therapeutics stock is rated a Sell
The current RAPT Therapeutics [RAPT] share price is $8.93. The Score for RAPT is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.